Ignite Creation Date:
2024-05-06 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06170671
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2023-12-06
Brief Title:
REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania
Sponsor:
Organization:
AstraZeneca